Medication Abortion

Guidance for providers on medication abortion provision up to 70 days gestation, the need for expanded access to the most effective forms of emergency contraception, the important role partner treatment can play in the treatment of bacterial vaginosis, and more.

Society of Family Planning’s clinical recommendations for contraceptive counseling for transgender and gender-expansive patients, the positive effect of levonorgestrel IUDs on female sexual function, barriers to abortion care within religious hospital systems, and more.

Improved access to abortion care during the COVID-19 pandemic through implementation of a no-test protocol for medication abortion, use of Lactin-V in treatment of recurrent bacterial vaginosis, importance of expanded access to postpartum contraceptive options to improve both maternal and fetal outcomes, and more.

The ACOG Committee Opinion’s stance on telehealth, an analysis of the safety and efficacy of self-administered vs. provider-administered medication abortion, influential factors in postpartum contraception use and short inter pregnancy intervals, and more.

What providers need to know about telehealth options for birth control, STI, abortion, and more.

What the research shows about telehealth’s safety, acceptability, and ability to improve access to sexual and reproductive health care services.

The importance of patient-centered contraceptive counseling, expedited scheduling of interval tubal ligation as a way to improve access to sterilization, a study of barriers to IUD access for adolescent patients, and more.

The ACOG Committee Opinion’s support for over-the-counter hormonal contraception, efficacy of intracervical blocks for pain management during levonorgestrel IUD placement, studies on the mechanism of function of ulipristal acetate, and more.